The influence of pretransplant transfusions, using different blood products, on patient sensitization and renal allograft survival

Fred Sanfilippo, William K. Vaughn, R. Randal Bollinger, Everett K. Spees

Research output: Contribution to journalArticle

Abstract

An analysis of data collected during the South Eastern Organ Procurement Foundation (SEOPF) Prospective Study from 1977–1982 was performed to identify the relative effects of different blood products on patient sensitization and graft survival in cadaveric donor renal transplant recipients. More than 2700 primary and 800 regrafted patients from 40 transplant centers were included in this study. A significant increase in actuarial graft survival was seen in primary recipients who had pretransplant transfusions with only frozen blood (P<0.003), washed blood (P <0.0005), packed blood (P <0.0001), or any combination of blood products (P <0.002) as compared with those who received no transfusions. No blood product was found to provide a significantly greater increase in graft survival than any other blood product. Likewise, regrafted patients had significant and equivalent increases in graft survival associated with each type of blood product examined. The increased graft survival associated with each blood product was the result of decreased graft rejection, and not apparently related to other differences among patients receiving different types of blood. Furthermore, the type of blood used in pretransplant transfusions did not significantly influence the degree of patient sensitization for first-graft recipients, although regrafted recipients who received packed blood or a combination of blood products showed a slightly greater degree of sensitization than those who received only frozen or washed blood. First-graft recipients given packed or mixed blood had a small, statistically insignificant increase of hepatitis B virus (HBV) antigenemia, compared with those receiving frozen, washed, or no blood. Regrafted patients given any type of transfusion had a 3—4-fold increased incidence of HBV antigenemia as compared with nontransfused patients, but this difference also was statistically not significant. These findings suggest that the benefits of increased graft survival and the risks of sensitization or HBV infection associated with pretransplant transfusions are not significantly affected by the type of blood used.

Original languageEnglish (US)
Pages (from-to)350-355
Number of pages6
JournalTransplantation
Volume37
Issue number4
StatePublished - 1984
Externally publishedYes

Fingerprint

Allografts
Kidney
Graft Survival
Hepatitis B virus
Transplants
Tissue and Organ Procurement
Graft Rejection
Virus Diseases

ASJC Scopus subject areas

  • Transplantation
  • Immunology

Cite this

The influence of pretransplant transfusions, using different blood products, on patient sensitization and renal allograft survival. / Sanfilippo, Fred; Vaughn, William K.; Randal Bollinger, R.; Spees, Everett K.

In: Transplantation, Vol. 37, No. 4, 1984, p. 350-355.

Research output: Contribution to journalArticle

Sanfilippo, F, Vaughn, WK, Randal Bollinger, R & Spees, EK 1984, 'The influence of pretransplant transfusions, using different blood products, on patient sensitization and renal allograft survival', Transplantation, vol. 37, no. 4, pp. 350-355.
Sanfilippo, Fred ; Vaughn, William K. ; Randal Bollinger, R. ; Spees, Everett K. / The influence of pretransplant transfusions, using different blood products, on patient sensitization and renal allograft survival. In: Transplantation. 1984 ; Vol. 37, No. 4. pp. 350-355.
@article{4f803cdf9c3f4e9ca380c9d3763d36d0,
title = "The influence of pretransplant transfusions, using different blood products, on patient sensitization and renal allograft survival",
abstract = "An analysis of data collected during the South Eastern Organ Procurement Foundation (SEOPF) Prospective Study from 1977–1982 was performed to identify the relative effects of different blood products on patient sensitization and graft survival in cadaveric donor renal transplant recipients. More than 2700 primary and 800 regrafted patients from 40 transplant centers were included in this study. A significant increase in actuarial graft survival was seen in primary recipients who had pretransplant transfusions with only frozen blood (P<0.003), washed blood (P <0.0005), packed blood (P <0.0001), or any combination of blood products (P <0.002) as compared with those who received no transfusions. No blood product was found to provide a significantly greater increase in graft survival than any other blood product. Likewise, regrafted patients had significant and equivalent increases in graft survival associated with each type of blood product examined. The increased graft survival associated with each blood product was the result of decreased graft rejection, and not apparently related to other differences among patients receiving different types of blood. Furthermore, the type of blood used in pretransplant transfusions did not significantly influence the degree of patient sensitization for first-graft recipients, although regrafted recipients who received packed blood or a combination of blood products showed a slightly greater degree of sensitization than those who received only frozen or washed blood. First-graft recipients given packed or mixed blood had a small, statistically insignificant increase of hepatitis B virus (HBV) antigenemia, compared with those receiving frozen, washed, or no blood. Regrafted patients given any type of transfusion had a 3—4-fold increased incidence of HBV antigenemia as compared with nontransfused patients, but this difference also was statistically not significant. These findings suggest that the benefits of increased graft survival and the risks of sensitization or HBV infection associated with pretransplant transfusions are not significantly affected by the type of blood used.",
author = "Fred Sanfilippo and Vaughn, {William K.} and {Randal Bollinger}, R. and Spees, {Everett K.}",
year = "1984",
language = "English (US)",
volume = "37",
pages = "350--355",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - The influence of pretransplant transfusions, using different blood products, on patient sensitization and renal allograft survival

AU - Sanfilippo, Fred

AU - Vaughn, William K.

AU - Randal Bollinger, R.

AU - Spees, Everett K.

PY - 1984

Y1 - 1984

N2 - An analysis of data collected during the South Eastern Organ Procurement Foundation (SEOPF) Prospective Study from 1977–1982 was performed to identify the relative effects of different blood products on patient sensitization and graft survival in cadaveric donor renal transplant recipients. More than 2700 primary and 800 regrafted patients from 40 transplant centers were included in this study. A significant increase in actuarial graft survival was seen in primary recipients who had pretransplant transfusions with only frozen blood (P<0.003), washed blood (P <0.0005), packed blood (P <0.0001), or any combination of blood products (P <0.002) as compared with those who received no transfusions. No blood product was found to provide a significantly greater increase in graft survival than any other blood product. Likewise, regrafted patients had significant and equivalent increases in graft survival associated with each type of blood product examined. The increased graft survival associated with each blood product was the result of decreased graft rejection, and not apparently related to other differences among patients receiving different types of blood. Furthermore, the type of blood used in pretransplant transfusions did not significantly influence the degree of patient sensitization for first-graft recipients, although regrafted recipients who received packed blood or a combination of blood products showed a slightly greater degree of sensitization than those who received only frozen or washed blood. First-graft recipients given packed or mixed blood had a small, statistically insignificant increase of hepatitis B virus (HBV) antigenemia, compared with those receiving frozen, washed, or no blood. Regrafted patients given any type of transfusion had a 3—4-fold increased incidence of HBV antigenemia as compared with nontransfused patients, but this difference also was statistically not significant. These findings suggest that the benefits of increased graft survival and the risks of sensitization or HBV infection associated with pretransplant transfusions are not significantly affected by the type of blood used.

AB - An analysis of data collected during the South Eastern Organ Procurement Foundation (SEOPF) Prospective Study from 1977–1982 was performed to identify the relative effects of different blood products on patient sensitization and graft survival in cadaveric donor renal transplant recipients. More than 2700 primary and 800 regrafted patients from 40 transplant centers were included in this study. A significant increase in actuarial graft survival was seen in primary recipients who had pretransplant transfusions with only frozen blood (P<0.003), washed blood (P <0.0005), packed blood (P <0.0001), or any combination of blood products (P <0.002) as compared with those who received no transfusions. No blood product was found to provide a significantly greater increase in graft survival than any other blood product. Likewise, regrafted patients had significant and equivalent increases in graft survival associated with each type of blood product examined. The increased graft survival associated with each blood product was the result of decreased graft rejection, and not apparently related to other differences among patients receiving different types of blood. Furthermore, the type of blood used in pretransplant transfusions did not significantly influence the degree of patient sensitization for first-graft recipients, although regrafted recipients who received packed blood or a combination of blood products showed a slightly greater degree of sensitization than those who received only frozen or washed blood. First-graft recipients given packed or mixed blood had a small, statistically insignificant increase of hepatitis B virus (HBV) antigenemia, compared with those receiving frozen, washed, or no blood. Regrafted patients given any type of transfusion had a 3—4-fold increased incidence of HBV antigenemia as compared with nontransfused patients, but this difference also was statistically not significant. These findings suggest that the benefits of increased graft survival and the risks of sensitization or HBV infection associated with pretransplant transfusions are not significantly affected by the type of blood used.

UR - http://www.scopus.com/inward/record.url?scp=0021255829&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021255829&partnerID=8YFLogxK

M3 - Article

C2 - 6369663

AN - SCOPUS:0021255829

VL - 37

SP - 350

EP - 355

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 4

ER -